Last Friday evening, the University of Michigan Health System and The Forbes Company, owners of the Somerset Collection, partnered in a “Maize and Blue Go Pink” benefit to support breast cancer research at the University of Michigan Comprehensive Cancer Center. With approximately 300 people in attendance, Nathan and Catherine Forbes, Dr. Ora Hirsch Pescovitz, University of Michigan Executive Vice President for Medical Affairs and U-M Health System CEO, and the Somerset Collection turned a tent in the middle of downtown Detroit into “The Pink House.”
The evening, emceed by former NFL and Wolverine standout Steven Hutchinson and his wife, Landyn, featured a strolling dinner provided by favorite restaurants from Detroit and Ann Arbor.
Special touches included maize and blue M&Ms, block “M” Legos and centerpieces constructed of products and memorabilia from both Detroit and U-M. But it was the incredibly stylish fashion show and amazing performances from The Vandellas and The Contours that crowned a truly spectacular evening!
While we are still tallying official numbers and will not have a final tally until the end of the month when the special silent auction currently happening at Somerset Collection closes, we are thrilled to share that our gross revenue to date for breast cancer research has surpassed $118,000, and continues to grow. If you are unable to make it over to Somerset Collection, you can still help out by making a donation.
Experience the evening in pictures.
The University of Michigan Comprehensive Cancer Center’s 1,000 doctors, nurses, care givers and researchers are united by one thought: to deliver the highest quality, compassionate care while working to conquer cancer through innovation and collaboration. The center is among the top-ranked national cancer programs, and #1 in Michigan for cancer patient care. Seventeen multidisciplinary clinics offer one-stop access to teams of specialists for personalized treatment plans, part of the ideal patient care experience. Patients also benefit through access to promising new cancer therapies.